These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
525 related items for PubMed ID: 10468620
1. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Meng L, Mohan R, Kwok BH, Elofsson M, Sin N, Crews CM. Proc Natl Acad Sci U S A; 1999 Aug 31; 96(18):10403-8. PubMed ID: 10468620 [Abstract] [Full Text] [Related]
2. Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology. Sin N, Kim KB, Elofsson M, Meng L, Auth H, Kwok BH, Crews CM. Bioorg Med Chem Lett; 1999 Aug 02; 9(15):2283-8. PubMed ID: 10465562 [Abstract] [Full Text] [Related]
3. Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones. Elofsson M, Splittgerber U, Myung J, Mohan R, Crews CM. Chem Biol; 1999 Nov 02; 6(11):811-22. PubMed ID: 10574782 [Abstract] [Full Text] [Related]
5. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20 S proteasome. Mellgren RL. J Biol Chem; 1997 Nov 21; 272(47):29899-903. PubMed ID: 9368065 [Abstract] [Full Text] [Related]
6. Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. Palombella VJ, Conner EM, Fuseler JW, Destree A, Davis JM, Laroux FS, Wolf RE, Huang J, Brand S, Elliott PJ, Lazarus D, McCormack T, Parent L, Stein R, Adams J, Grisham MB. Proc Natl Acad Sci U S A; 1998 Dec 22; 95(26):15671-6. PubMed ID: 9861028 [Abstract] [Full Text] [Related]
7. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL. Science; 1995 May 05; 268(5211):726-31. PubMed ID: 7732382 [Abstract] [Full Text] [Related]
9. Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency. Kim KB, Myung J, Sin N, Crews CM. Bioorg Med Chem Lett; 1999 Dec 06; 9(23):3335-40. PubMed ID: 10612595 [Abstract] [Full Text] [Related]
12. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors. Demasi M, Shringarpure R, Davies KJ. Arch Biochem Biophys; 2001 May 15; 389(2):254-63. PubMed ID: 11339815 [Abstract] [Full Text] [Related]
15. Specific inhibition of the chymotrypsin-like activity of the proteasome induces a bipolar morphology in neuroblastoma cells. Fenteany G, Schreiber SL. Chem Biol; 1996 Nov 15; 3(11):905-12. PubMed ID: 8939705 [Abstract] [Full Text] [Related]
17. Components of the bovine pituitary multicatalytic proteinase complex (proteasome) cleaving bonds after hydrophobic residues. Cardozo C, Michaud C, Orlowski M. Biochemistry; 1999 Jul 27; 38(30):9768-77. PubMed ID: 10423257 [Abstract] [Full Text] [Related]
18. Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. Tsubuki S, Saito Y, Tomioka M, Ito H, Kawashima S. J Biochem; 1996 Mar 27; 119(3):572-6. PubMed ID: 8830056 [Abstract] [Full Text] [Related]
19. Involvement of proteasome in endothelin-1 production in cultured vascular endothelial cells. Ohkita M, Takaoka M, Kobayashi Y, Itoh E, Uemachi H, Matsumura Y. Jpn J Pharmacol; 2002 Feb 27; 88(2):197-205. PubMed ID: 11928721 [Abstract] [Full Text] [Related]